These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 32585249)

  • 21. [Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis].
    Sugimoto H
    Yakugaku Zasshi; 2010 Apr; 130(4):521-6. PubMed ID: 20371996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease.
    Chan HH; Koh RY; Lim CL; Leong CO
    Curr Alzheimer Res; 2019; 16(10):907-918. PubMed ID: 31642777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
    Belluti F; Rampa A; Gobbi S; Bisi A
    Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targets, trials and tribulations in Alzheimer therapeutics.
    Gharat R; Dixit G; Khambete M; Prabhu A
    Eur J Pharmacol; 2024 Jan; 962():176230. PubMed ID: 38042464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.
    Zheng C; Lan Y; Zhang J; Zhang L; Wu J; Guo S
    Acta Pol Pharm; 2016 Jul; 73(4):835-842. PubMed ID: 29648708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New trends in the design of drugs against Alzheimer's disease.
    Francotte P; Graindorge E; Boverie S; de Tullio P; Pirotte B
    Curr Med Chem; 2004 Jul; 11(13):1757-78. PubMed ID: 15279580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-targetable chalcone analogs to treat deadly Alzheimer's disease: Current view and upcoming advice.
    Zhang X; Rakesh KP; Bukhari SNA; Balakrishna M; Manukumar HM; Qin HL
    Bioorg Chem; 2018 Oct; 80():86-93. PubMed ID: 29890362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.
    Guo X; Jiang W; Li C; Zhu Z; Shen X
    Rev Neurosci; 2015; 26(1):13-30. PubMed ID: 25720054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
    Haas C
    J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.